CRScube

Founded in 2020 and headquartered in San Francisco, CRScube is a private, revenue-generating company operating in the Digital Health, AI/Machine Learning, and Clinical Research sectors. It offers a suite of integrated, compliant software modules (cubeCDMS, cubeSAFETY, cubeCTMS, etc.) that support the entire clinical trial lifecycle from setup to data analysis. The company serves over 1,000 clients globally, positioning itself as a cost-effective and user-centric alternative to legacy clinical technology providers. Its growth is driven by the increasing demand for decentralized trial capabilities and operational efficiency in drug development.

A unified, modular eClinical software suite (cube platform) featuring integrated modules for EDC (cubeCDMS), safety reporting (cubeSAFETY), trial management (cubeCTMS), eTMF, eConsent, ePRO, and RTSM. The cloud-based platform emphasizes seamless integration, user-centric design, regulatory compliance (FDA 21 CFR Part 11, EMA, ISO), and cost-effective scalability.

CRScube competes in the fragmented eClinical technology market against large suite providers like Veeva Vault Clinical, Medidata Rave, and Oracle Health Sciences, as well as numerous best-of-breed point solutions. Its differentiation hinges on offering a unified platform at a lower cost with a strong emphasis on user experience and rapid implementation, targeting cost-conscious small-to-midsize sponsors and CROs.